We propose to utilize HPV-positive organoid models and patient-derived xenografts to functionally test whether the competitive displacement of TFAP2 by YY1 drives hallmark cancer phenotypes such as sustained proliferation, invasion, and in vivo tumor growth. Here, YY1 is linked to cancer.